SHIRE PHARMACEUTICAL CONTRACTS LIMITED

Active London

Other service activities n.e.c.

0 employees website.com
Other service activities n.e.c.
S

SHIRE PHARMACEUTICAL CONTRACTS LIMITED

Other service activities n.e.c.

Founded 2 Jun 1986 Active London, United Kingdom 0 employees website.com
Other service activities n.e.c.

Previous Company Names

IMPERIAL PHARMACEUTICAL SERVICES LIMITED 16 Jan 1989 — 22 Sept 1995
SCRIPT LIMITED 29 Sept 1986 — 16 Jan 1989
SERCLANE LIMITED 2 Jun 1986 — 29 Sept 1986
Accounts Submitted 26 Nov 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 11 Jul 2025 Next due 12 Jul 2026 1 month remaining
Net assets £441K £6K 2024 year on year
Total assets £441K £2M 2024 year on year
Total Liabilities £0 £2M 2024 year on year
Charges 4
4 satisfied

Contact & Details

Contact

Registered Address

1 Kingdom Street London W2 6BD United Kingdom

Full company profile for SHIRE PHARMACEUTICAL CONTRACTS LIMITED (02024595), an active company based in London, United Kingdom. Incorporated 2 Jun 1986. Other service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Net Assets

£441.00k

Decreased by £6.00k (-1%)

Total Liabilities

N/A

Decreased by £2.04M (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 82 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Takeda Uk Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Takeda Uk Limited

United Kingdom

Active
Notified 21 Dec 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Shire Plc

Ceased 8 Jan 2019

Ceased

Shire Pharmaceuticals Group

Ceased 21 Dec 2022

Ceased

Takeda Pharmaceutical Company Limited

Ceased 13 Dec 2019

Ceased

Group Structure

Group Structure

TAKEDA UK LIMITED united kingdom
SHIRE PHARMACEUTICAL CONTRACTS LIMITED Current Company

Charges

Charges

4 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Nov 2025AccountsAnnual accounts made up to 31 Mar 2025
10 Sept 2025OfficersTermination of Peter Michael Grubin as director on 2 Sept 2025
11 Jul 2025Confirmation StatementConfirmation statement made on 28 Jun 2025 with no updates
10 Jul 2025OfficersChange to director Mr Peter Michael Grubin on 29 May 2025
18 Dec 2024AccountsAnnual accounts made up to 31 Mar 2024
26 Nov 2025 Accounts

Annual accounts made up to 31 Mar 2025

10 Sept 2025 Officers

Termination of Peter Michael Grubin as director on 2 Sept 2025

11 Jul 2025 Confirmation Statement

Confirmation statement made on 28 Jun 2025 with no updates

10 Jul 2025 Officers

Change to director Mr Peter Michael Grubin on 29 May 2025

18 Dec 2024 Accounts

Annual accounts made up to 31 Mar 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

6 months ago on 26 Nov 2025

Termination of Peter Michael Grubin as director on 2 Sept 2025

8 months ago on 10 Sept 2025

Confirmation statement made on 28 Jun 2025 with no updates

10 months ago on 11 Jul 2025

Change to director Mr Peter Michael Grubin on 29 May 2025

10 months ago on 10 Jul 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 18 Dec 2024